Financials

  • Market Capitalization 23.61 M
  • Employee 224
  • Founded 2008
  • CEO N/A
  • Website www.cardlytics.com
  • Headquarter Delaware, United States
  • FIGI BBG00225ZDD0
  • Industry Advertising
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.24
Price to sales ratio
0.13

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4445
SWAG
Stran & Company, Inc. - Common Stock
1.71 USD-2.29%-7.57%-16.18%+1.79%31.87 M USD
4502
WIMI
WiMi Hologram Cloud Inc. - Class B Ordinary Shares
1.37 USD+0.74%+2.24%+19.13%-20.35%25.19 M USD
4560
ACCS
ACCESS Newswire Inc. Common Stock
5.54 USD+7.57%+10.80%-21.08%-21.16%21.20 M USD
4648
TULP
Bloomia Holdings, Inc. - Common Stock
3.40 USD0.00%0.00%+0.59%-33.59%16.23 M USD

Frequently asked questions about Cardlytics, Inc. Common Stock

What is the Cardlytics, Inc. Common Stock stock price today?

The current price of Cardlytics, Inc. Common Stock (CDLX) is 4.01. Over the past 24 hours, the stock has changed by -2.91%. Follow the CDLX chart for real-time price dynamics.

What is the stock ticker of Cardlytics, Inc. Common Stock?

Cardlytics, Inc. Common Stock trades under the ticker CDLX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Cardlytics, Inc. Common Stock stock going up?

CDLX has changed by -6.74% over the last week, +4.43% over the last month, and +271.30% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Cardlytics, Inc. Common Stock?

Cardlytics, Inc. Common Stock currently has a market capitalization of 23.61 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Does Cardlytics, Inc. Common Stock release financial reports?

Yes. You can track Cardlytics, Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What were Cardlytics, Inc. Common Stock earnings last quarter?

Last quarter, Cardlytics, Inc. Common Stock reported earnings of -2.58 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Cardlytics, Inc. Common Stock revenue for the last quarter?

Cardlytics, Inc. Common Stock reported quarterly revenue of 36.88 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Cardlytics, Inc. Common Stock net income for the last quarter?

Cardlytics, Inc. Common Stock reported net income of -14.88 M for the last quarter. The previous quarter showed -4.48 M, which means net income changed by -232.05%.

How many employees does Cardlytics, Inc. Common Stock have?

As of the latest available data, Cardlytics, Inc. Common Stock has 224 employees. Workforce size can provide additional context about the company's scale and operations.

What is Cardlytics, Inc. Common Stock EBITDA?

Cardlytics, Inc. Common Stock EBITDA is -1.38 M, and its EBITDA margin is -3.74%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Cardlytics, Inc. Common Stock stock?

You can buy Cardlytics, Inc. Common Stock (CDLX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Cardlytics, Inc. Common Stock stock?

Investing in Cardlytics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CDLX chart and related analysis on metatrader.com as part of your research.

News